Literature DB >> 8339275

Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance.

F S Wang1, C Aschele, A Sobrero, Y M Chang, J R Bertino.   

Abstract

HCT-8 cells become rapidly resistant to either 4-h (HCT-8/4hR) or 7-day (HCT-8/7dR) repeated exposures to fluorouracil (FUra). The HCT-8/7dR cells were studied in more detail to determine their mechanism of resistance to FUra. Thymidylate synthase activity, binding of 5-fluorodeoxyuridylate to thymidylate synthase, and incorporation of FUra into RNA were not different between the parental and resistant sublines. However, folylpolyglutamate synthetase activity was markedly decreased in this subline using tetrahydrofolate, 5,10-methylenetetrahydrofolate, and methotrexate as substrates. Northern blot analysis revealed decreased folylpolyglutamate synthetase mRNA expression in HCT-8/7dR cells as compared to HCT-8 cells. These findings indicate that low-dose continuous exposure schedules to FUra are cytotoxic primarily due to inhibition of thymidylate synthase and underscores the role of 5,10-methylenetetrahydrofolate polyglutamates in this inhibition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339275

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?

Authors:  Barry Iacopetta; Kazuyuki Kawakami; Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

2.  Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.

Authors:  K-J Sohn; F Smirnakis; D N Moskovitz; P Novakovic; Z Yates; M Lucock; R Croxford; Y-I Kim
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

3.  Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours.

Authors:  H L McLeod; J Sludden; G I Murray; R A Keenan; A I Davidson; K Park; M Koruth; J Cassidy
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.

Authors:  M Inaba; H Sawada; A Sadata; H Hamada
Journal:  Jpn J Cancer Res       Date:  1999-03

5.  Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure.

Authors:  M Inaba; T Tanaka; H Sawada
Journal:  Jpn J Cancer Res       Date:  1998-03

Review 6.  Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression.

Authors:  Kevinn Eddy; Mohamad Naser Eddin; Anna Fateeva; Stefano Vito Boccadamo Pompili; Raj Shah; Saurav Doshi; Suzie Chen
Journal:  Cells       Date:  2022-09-13       Impact factor: 7.666

7.  Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.

Authors:  M Hejna; G V Kornek; M Raderer; D Depisch; T Brodowicz; W C Fiebiger; W Scheithauer
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

8.  γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexate.

Authors:  S-E Kim; P D Cole; R C Cho; A Ly; L Ishiguro; K-J Sohn; R Croxford; B A Kamen; Y-I Kim
Journal:  Br J Cancer       Date:  2013-09-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.